For pregnant women who received the bivalent prefusion F subunit-based respiratory syncytial virus (RSV) vaccine (RSVpreF; ...

“Our findings indicate that the vaccine provided a significant enhanced level of protection against these infections in the ...

In 2023, the FDA and CDC's Advisory Committee on Immunization Practices (ACIP) voted in favor of recommending the monoclonal ...

An analysis of safety data suggests that Abrysvo, the Pfizer respiratory syncytial virus (RSV) RSVpreF vaccine, does not ...

The complaint alleges that Moderna used the patented fluorescent protein technology without permission during preclinical ...

The CDC on Monday dramatically reduced the number of vaccines it recommends for all children. Here’s what parents should know ...

Respiratory syncytial virus (RSV) remains a leading cause of severe lower respiratory infections among infants, particularly ...

The abrupt change in the U.S. childhood vaccine schedule from 17 vaccines to 11 belies promises to the American people that ...

Preliminary Q4 2025 PEMGARDA® (pemivibart) net product revenue of $17.2 million, representing 25% growth year-over-year and 31% growth ...

Clinicians say federal changes to CDC childhood recommendations have spurred questions despite California’s move to follow ...

The Centers for Disease Control and Prevention announced Monday sweeping changes to the country's routine childhood vaccine ...